Logo
x

Search

Subscribe Now

Junipera Study

Novartis Presents Two-Year Data of Cosentyx (secukinumab) in P-III JUNIPERA Study for JPsA and ERA at ACR 2021

Novartis Presents Two-Year Data of Cosentyx (secukinumab) in P-III JUNIPERA Study for JPsA and ERA at ACR 2021

  • November 9, 2021
Novartis Presents Two-Year Data of Cosentyx in P-III JUNIPERA Study for JPsA and ERA at EULAR 2021

Novartis Presents Two-Year Data of Cosentyx in P-III JUNIPERA Study for JPsA and ERA at EULAR 2021

  • June 2, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.